Stocks · Health care · Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc.

DNA Clue Score24
United States Fiscal year ends December CIK 0001830214 Results filed 5 Nov 2026

What the insiders did Net selling

By person

12 insiders · 24 transactions
5.2×

Jason Kelly holds 5.2 times base salary in stock. $1.31M of shares against $250.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Kelly last reported holding, valued at $10.14, the price Class A Common Stock was last bought or sold at on the open market here, on 19 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Jason R Kelly
See remarks
—
$1.84M (3)
−$1.84M
129,065
0.2026%
$1.31M
—
Barry Canton
10% owner
—
$1.40M (5)
−$1.40M
1,246,702
1.96%
$12.65M
+18.2%
Reshma P. Shetty
See remarks
—
$1.40M (5)
−$1.40M
1,148,848
1.80%
$11.65M
+20.0%
Steven P. Coen
See remarks
—
$289.93K (10)
−$289.93K
50,168
0.0787%
$508.85K
+677.1%
Christian O Henry
Director
—
$35.41K (1)
−$35.41K
19,310
0.0303%
$195.86K
−42.3%
Harry Sloan
Director
—
—
—
271,418
0.4260%
$2.75M
+1,218%
Shyam Sankar
Director
—
—
—
72,372
0.1136%
$734.07K
+17.6%
Mark E. Dmytruk
See remarks
—
—
—
46,226
0.0726%
$468.87K
+46.2%
Sri Kosuri
Director
—
—
—
24,067
0.0378%
$244.11K
—
Kathy Hopinkah Hannan
Director
—
—
—
15,003
0.0235%
$152.18K
+258.8%
Myrtle S Potter
Director
—
—
—
10,822
0.0170%
$109.77K
—
Ross Fubini
Director
—
—
—
10,822
0.0170%
$109.77K
—